The safety and clinical efficacy of recombinant human granulocyte colony stimulating factor injection for colon cancer patients undergoing chemotherapy
Author:
Affiliation:
1. Northern Jiangsu People's Hospital, China
2. Jilin University, China
Publisher
FapUNIFESP (SciELO)
Subject
General Medicine
Link
http://www.scielo.br/pdf/ramb/v63n12/0104-4230-ramb-63-12-1061.pdf
Reference18 articles.
1. Global patterns of cancer incidence and mortality rates and trends;Jemal A;Cancer Epidemiol Biomarkers Prev,2010
2. National Comprehensive Cancer Network. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines;Benson AB;J Natl Compr Canc Netw,2013
3. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines;3rd Benson AB;J Natl Compr Canc Netw,2013
4. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy;Caggiano V;Cancer,2005
5. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy a systematic review;Kuderer NM;J Clin Oncol,2007
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mesenchymal stem cells cause induction of granulocyte differentiation of rat bone marrow C-kit plus hematopoietic stem cells through JAK3/STAT3, ERK, and PI3K signaling pathways;IRAN J BASIC MED SCI;2022
2. Efficacy and Safety of Filgrastim and Its Biosimilars to Prevent Febrile Neutropenia in Cancer Patients: A Prospective Study and Meta-Analysis;Biology;2021-10-19
3. Clinical efficacy and safety of mecapegfilgrastim in small cell lung cancer as primary prophylaxis of neutropenia post chemotherapy: a retrospective analysis;Annals of Palliative Medicine;2021-07
4. Neutropenia febril inducida por quimioterapia e infecciones asociadas: una revisión de la literatura;Gaceta Mexicana de Oncolog�a;2019-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3